
As Needed Inhaled Glucocorticoid Plus Usual Controller Therapy Reduces Severe Asthma Exacerbations, Improves Asthma Control in African American & Hispanic/Latinx Patients
PHOENIX, Feb. 26, 2022 /PRNewswire-PRWeb/ — A patient-activated, reliever-triggered inhaled glucocorticoid strategy, combined with usual care, reduces asthma exacerbations and improves asthma control and quality of life in African American and Hispanic/Latinx adult patients with